Global Infectious Disease Therapeutics Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: July 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Infectious Disease Therapeutics Market was valued at $158 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 5.8% CAGR, to an estimated market size of $210 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global infectious disease therapeutics market comprises the development, manufacturing, and distribution of pharmaceutical drugs and vaccines designed to treat or prevent infections caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites. The scope includes anti-infective classes such as antivirals, antibiotics, and antifungals, as well as advanced modalities like monoclonal antibodies and mRNA-based therapies, while excluding general diagnostic services not bundled with therapeutic delivery.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Infectious Disease Therapeutics Market in the period 2025-30:
- The rapid expansion of mRNA technology and monoclonal antibodies is revolutionizing the speed of vaccine development and the efficacy of antiviral treatments.
- Integration of Artificial Intelligence in drug discovery is significantly shortening clinical trial timelines and reducing the scientific risk of developing new anti-infectives.
- Rising Antimicrobial Resistance (AMR) is compelling governments to provide increased funding and accelerated regulatory pathways for novel, broad-spectrum antibiotics.
- A strategic shift toward long-acting injectables is improving patient adherence, particularly in the management of chronic conditions like HIV and Hepatitis.
- Increased global focus on pandemic preparedness is driving massive public-private investments in vaccine stockpiling and rapid-response therapeutic platforms.
- The growing incidence of zoonotic diseases and climate-related shifts in pathogen habitats are creating sustained demand for specialized treatments in emerging markets.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Asia-Pacific
- Europe
- Rest of World
Segments
- Antiviral Drugs
- Antibiotic Drugs
- Antifungals and Others